Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Antiangiogenic and anticancer molecules in cartilage.

Patra D, Sandell LJ.

Expert Rev Mol Med. 2012 Jan 19;14:e10. doi: 10.1017/erm.2012.3. Review.

PMID:
22559283
2.

Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.

Pufe T, Petersen WJ, Miosge N, Goldring MB, Mentlein R, Varoga DJ, Tillmann BN.

Matrix Biol. 2004 Aug;23(5):267-76.

PMID:
15464359
3.

Shark cartilage as source of antiangiogenic compounds: from basic to clinical research.

González RP, Leyva A, Moraes MO.

Biol Pharm Bull. 2001 Oct;24(10):1097-101. Review.

4.

Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue.

Dupont E, Falardeau P, Mousa SA, Dimitriadou V, Pepin MC, Wang T, Alaoui-Jamali MA.

Clin Exp Metastasis. 2002;19(2):145-53.

PMID:
11964078
5.

Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?

Gingras D, Renaud A, Mousseau N, Béliveau R.

Cancer Metastasis Rev. 2000;19(1-2):83-6. Review.

PMID:
11191068
6.

Neovastat--a novel antiangiogenic drug for cancer therapy.

Gingras D, Boivin D, Deckers C, Gendron S, Barthomeuf C, Béliveau R.

Anticancer Drugs. 2003 Feb;14(2):91-6. Review.

PMID:
12569294
7.

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

Falardeau P, Champagne P, Poyet P, Hariton C, Dupont E.

Semin Oncol. 2001 Dec;28(6):620-5. Review.

PMID:
11740820
8.

Developing antiangiogenic peptide drugs for angiogenesis-related diseases.

Sulochana KN, Ge R.

Curr Pharm Des. 2007;13(20):2074-86.

PMID:
17627540
9.

Novel functions for type II procollagen.

Sandell LJ.

Connect Tissue Res. 2014 Jan-Feb;55(1):20-5. doi: 10.3109/03008207.2013.867340. Review.

PMID:
24437601
10.

Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin.

Hiraki Y, Shukunami C.

Connect Tissue Res. 2005;46(1):3-11. Review.

PMID:
16019413
11.

[Antiangiogenic and antitumor properties of cartilage].

Korman DB.

Vopr Onkol. 2012;58(6):717-26. Review. Russian. No abstract available.

PMID:
23600294
12.

Marine-derived angiogenesis inhibitors for cancer therapy.

Wang YQ, Miao ZH.

Mar Drugs. 2013 Mar 15;11(3):903-33. doi: 10.3390/md11030903. Review.

14.

Collagen XVIII/endostatin structure and functional role in angiogenesis.

Zatterstrom UK, Felbor U, Fukai N, Olsen BR.

Cell Struct Funct. 2000 Apr;25(2):97-101. Review.

15.

Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin.

Rabbani-Chadegani A, Abdossamadi S, Bargahi A, Yousef-Masboogh M.

J Pharm Biomed Anal. 2008 Feb 13;46(3):563-7. Epub 2007 Nov 1.

PMID:
18093782
16.

Antiangiogenic therapy.

Albo D, Wang TN, Tuszynski GP.

Curr Pharm Des. 2004;10(1):27-37. Review.

PMID:
14754403
17.

The clinical potential of antiangiogenic fragments of extracellular matrix proteins.

Clamp AR, Jayson GC.

Br J Cancer. 2005 Oct 31;93(9):967-72. Review.

18.

AE-941 (Neovastat): a novel multifunctional antiangiogenic compound.

Gingras D, Batist G, Béliveau R.

Expert Rev Anticancer Ther. 2001 Oct;1(3):341-7.

PMID:
12113101
19.

Sharks: a potential source of antiangiogenic factors and tumor treatments.

Cho J, Kim Y.

Mar Biotechnol (NY). 2002 Dec;4(6):521-5.

PMID:
14961226
20.

Tumor angiogenesis inhibitors.

Kiselev SM, Lutsenko SV, Severin SE, Severin ES.

Biochemistry (Mosc). 2003 May;68(5):497-513. Review.

PMID:
12882631

Supplemental Content

Support Center